✦ LIBER ✦

The treatment of recurrent or metastatic breast cancer

✍ Scribed by Howard B. Andereont

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1–14 Impact of FDG PET on Defining the E

✍ Kim, E.E. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 111 KB

The Breast Avastin Trial: phase II study

✍ Bisagni, G.; Musolino, A.; Panebianco, M.; Matteis, A.; Nuzzo, F.; Ardizzoni, A. 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 256 KB

Efficacy and safety of bevacizumab in co

✍ Xavier Pivot; Andreas Schneeweiss; Shailendra Verma; Christoph Thomssen; José Lu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 531 KB

476 PFS by patient subgroup for standard

✍ I. Bondarenko; J. Glaspy; A. Brufsky; O. Lipatov; E.A. Perez; S. Chan; X. Zou; S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Symptomatology as an indicator of recurr

✍ David P. Winchester; Stephen F. Sener; Janardan D. Khandekar; Miguel A. Oviedo; 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB 👁 2 views

Treatment of metastatic breast cancer

✍ Vogel, Charles L. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 598 KB